Bullseye Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Buy
238,443
+1,583
+0.7% +$15.3K 1.77% 26
2026
Q1
$1.76M Hold
236,860
1.02% 45
2025
Q4
$2.79M Hold
236,860
1.5% 29
2025
Q3
$1.83M Buy
236,860
+10,000
+4% +$70K 0.96% 43
2025
Q2
$1.66M Buy
226,860
+10,000
+5% +$80.7K 0.83% 45
2025
Q1
$2.06M Buy
216,860
+55,000
+34% +$687K 1.11% 37
2024
Q4
$2.67M Sell
161,860
-1,932
-1% -$30K 1.25% 33
2024
Q3
$2.42M Hold
163,792
1.11% 35
2024
Q2
$2.27M Hold
163,792
1.11% 40
2024
Q1
$2.58M Hold
163,792
1.21% 33
2023
Q4
$2.65M Hold
163,792
1.27% 31
2023
Q3
$2.02M Buy
163,792
+26,819
+20% +$399K 1.12% 38
2023
Q2
$2.2M Hold
136,973
1.11% 36
2023
Q1
$2.38M Buy
136,973
+30,976
+29% +$441K 1.22% 35
2022
Q4
$980K Hold
105,997
0.53% 59
2022
Q3
$913K Sell
105,997
-2,275
-2% -$22.6K 0.53% 57
2022
Q2
$883K Buy
108,272
+218
+0.2% +$2.08K 0.5% 59
2022
Q1
$1.31M Hold
108,054
0.6% 58
2021
Q4
$3.62M Hold
108,054
1.43% 28
2021
Q3
$5.21M Sell
108,054
-618
-0.6% -$28.6K 1.81% 15
2021
Q2
$4.91M Hold
108,672
1.65% 19
2021
Q1
$5.24M Hold
108,672
1.96% 13
2020
Q4
$5.85M Sell
108,672
-1,593
-1% -$72K 2.18% 10
2020
Q3
$4.07M Sell
110,265
-120
-0.1% -$4.46K 1.85% 13
2020
Q2
$3.42M Buy
110,385
+23,975
+28% +$664K 1.83% 16
2020
Q1
$2.39M Sell
86,410
-52,445
-38% -$1.57M 2.84% 6
2019
Q4
$4.06M Buy
+138,855
New +$3.31M 3.93% 4

Other funds holding NEO

Bullseye Asset Management's NEO Position: Q2 2026 in Review

Bullseye Asset Management increased its NeoGenomics (NEO) stake by 0.67% in Q2 2026, buying an estimated $15.3K and bringing the position to 238,443 shares worth $3.48M. The position accounts for 1.77% of the portfolio, ranked #26.

Bullseye Asset Management first reported a position in NEO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.85M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Bullseye Asset Management held 238,443 shares of NeoGenomics worth $3.48M as of Q2 2026.
  • Bullseye Asset Management bought 1,583 NeoGenomics shares in Q2 2026, an estimated $15.3K.
  • NeoGenomics made up 1.77% of Bullseye Asset Management's portfolio in Q2 2026, its #26 holding.
  • Bullseye Asset Management first reported a position in NeoGenomics in Q4 2019 and has held it in 27 quarters since.
  • Bullseye Asset Management's NeoGenomics position peaked at $5.85M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Bullseye Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.